Decreased interstitial FOXP3+ lymphocytes in usual interstitial pneumonia with discrepancy of CXCL12/CXCR4 axis

International Journal of Immunopathology and Pharmacology

Volumn 23, Issue 2, 2010, Pages 449-461

  Shimizu, Yasuo ^a,b   Dobashi, K ^c   Endou, K ^a   Ono, A ^a   Yanagitani, N ^a   Utsugi, M ^a   Sano, T ^a   Ishizuka, T ^a   Shimizu, K ^a   Tanaka, S ^a   Mori, M ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

CXCL12; CXCR4; FOXP3; Idiopathic pulmonary fibrosis; Regulatory T cell

Indexed keywords

CD20 ANTIBODY; CD3 ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; CD25+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERSTITIAL PNEUMONIA; INTERSTITIUM; LUNG FIBROSIS; LUNG PARENCHYMA; LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TISSUE; UPREGULATION;

EID: 77955363238     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201002300207     Document Type: Article

References (23)

1. Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996; 382:635-8. (Pubitemid 26268957)
2. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002; 165:277-304.
3. Mehrad B, Burdick MD, Zisman DA, Keane MP, Belperio JA, Strieter RM. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun 2007; 353:104-08. (Pubitemid 44958347)
4. Yang IV, Burch LH, Steele MP, et al. Gene expression profiling of familial and sporadic interstitial pneumonia. Am J Respir Crit Care Med 2007; 175:45-54.
5. Xu J, Mora A, Shim H, Stecenko A, Brigham KL, Rojas M. Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis. Am J Respir Cell Mol Biol 2007; 37:291-9. (Pubitemid 350067608)
6. Hashimoto N, Jin H, Liu T, Chensue SW, Phan SH. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 2004; 113:243-52. (Pubitemid 38544209)
7. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, Belperio JA, Keane MP, Strieter RM. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004; 114:438-46. (Pubitemid 39071616)
8. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133:775-87.
9. Kotsianidis I, Nakou E, Bouchliou I, et al. Global Impairment of CD4+CD25+FOXP3+ T regulatory cells in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009; 179:1121-30.
10. + T cells undergo conventional first switch to lymphoid tissue homing receptors in thymus but accelerated second switch to nonlymphoid tissue homing receptors in secondary lymphoid tissues. J Immunol 2007; 178:301-11.
11. Shimizu Y, Kuwabara H, Ono A, Higuchi S, Hisada T, Dobashi K, Utsugi M, Mita Y, Mori M. Intracellular Th1/Th2 balance of pulmonary CD4(+) T cells in patients with active interstitial pneumonia evaluated by serum KL-6. Immunopharmacol Immunotoxicol 2006; 28:295-304. (Pubitemid 44180246)
12. Shimizu Y, Dobashi K, Imai H, et al. CXCR4+FOXP3+CD25+ lymphocytes accumulate in CXCL12-expressing malignant pleural mesothelioma. Int J Immunopathol Pharmacol 2009; 22:43-51.
13. Shimizu Y, Dobashi K, Iizuka K, Horie T, Suzuki K, Tukagoshi H, Nakazawa T, Nakazato Y, Mori M. Contribution of small GTPase Rho and its target protein rock in a murine model of lung fibrosis. Am J Respir Crit Care Med 2001; 163:210-17. (Pubitemid 32095272)
14. Hayashi T, Stetler-Stevenson WG, Fleming MV, Fishback N, Koss MN, Liotta LA, Ferrans VJ, Travis WD. Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am J Pathol 1996; 149:1241-56. (Pubitemid 26337243)
15. Nicholson AG, Fulford LG, Colby TV, du Bois RM, Hansell DM, Wells AU. The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002; 166:173-7.
16. Imai H, Sunaga N, Shimizu Y, Kakegawa S, Shimizu K, Sano T, Ishizuka T, Oyama T, Saito R, Minna JD. Clinicopathological and therapeutic significance of CXCL12 expression in lung cancer. Int J Immunopathol Pharmacol 2010; 23:153-64.
17. Hashimoto S, Gon Y, Takeshita I, Matsumoto K, Maruoka S, Horie T. Transforming growth Factor-beta1 induces phenotypic modulation of human lung fibroblasts to myofibroblast through a c-Jun-NH2-terminal kinase-dependent pathway. Am J Respir Crit Care Med 2001; 163:152-7. (Pubitemid 32095266)
18. Utsugi M, Dobashi K, Ishizuka T, Masubuchi K, Shimizu Y, Nakazawa T, Mori M. C-Jun-NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-beta1 in human lung fibroblasts. Am J Respir Cell Mol Biol 2003; 28:754-61. (Pubitemid 36677180)
19. Koike Y, Hisada T, Utsugi M, et al. Glutathione redox regulates airway hyperresponsiveness and airway inflammation in mice. Am J Respir Cell Mol Biol 2007; 37:322-9. (Pubitemid 350067611)
20. Choi ES, Pierce EM, Jakubzick C. Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia. J Clin Pathol 2006; 59:28-39. (Pubitemid 43076236)
21. Breul SD, Bradley KH, Hance AJ, Schafer MP, Berg RA, Crystal RG. Control of collagen production by human diploid lung fibroblasts. J Biol Chem 1980; 255:5250-60.
22. Ono A, Utsugi M, Masubuchi K, et al. Glutathione redox regulates TGF-beta-induced fibrogenic effects through Smad3 activation. FEBS Lett 2009; 583:357-62.
23. Zheng Y, Chaudhry A, Kas A, et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 2009; 458:351-6.